FMS - Fresenius Medical Care Non-GAAP EPS of Euro0.68 revenue of Euro4.55B
Fresenius Medical Care (NYSE:FMS): Q1 Non-GAAP EPS of €0.68. Revenue of €4.55B (+8.1% Y/Y). The Company expects revenue and net income to grow at low to mid-single digit percentage rates in FY 2022
For further details see:
Fresenius Medical Care Non-GAAP EPS of €0.68, revenue of €4.55B